To undermine the effectiveness and molecular mechanisms related to DC-CIK cells and GBM cells, we investigated several parameters such as release of IFN-γ, TNF-α and expression level of WNT/beta-catenin pathway. This evidence concerns the gene CTNNB1 and glioblastoma.